Skip to Content

WPI 3631 (Hydromorphone Hydrochloride Extended-Release 32 mg)

Pill with imprint WPI 3631 is White, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 32 mg. It is supplied by Actavis Pharma, Inc..

Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3631

Hydromorphone hydrochloride extended-release 32 mg WPI 3631

Hydromorphone Hydrochloride Extended-Release

WPI 3631
32 mg
10.00 mm
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
cellulose acetate, copovidone, hypromelloses, ferrosoferric oxide, lactose monohydrate, magnesium stearate, polyethylene glycol, propylene glycol, sodium chloride, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.